Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rowe

Showing results (511-520 of 632) with videos related to

Pageof 64
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 29, 2024
CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PETAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
JAMA Network Open|May 6, 2022
Mistreatment Experiences, Protective Workplace Systems, and Occupational Distress in PhysiciansSusannah G Rowe, Miriam T Stewart, Sam Van Horne, et al.
Nature Communications|February 29, 2020
Cation-controlled wetting properties of vermiculite membranes and its promise for fouling resistant oil-water separationK Huang, P Rowe, C Chi, et al.
Molecular Imaging|June 30, 2020
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [<sup>124</sup>I]FIAU PET/CTSteve Y Cho, Steven P Rowe, Sanjay K Jain, et al.
Diagnostic and Interventional Imaging|August 2, 2025
Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor typesJorge D Oldan, Anurag Anugu, Md Zobaer Islam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand TherapyPhilipp E Hartrampf, Patrick W Mihatsch, Anna Katharina Seitz, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 28, 2015
Prostate-specific membrane antigen as a target for cancer imaging and therapyA P Kiess, S R Banerjee, R C Mease, et al.
AJR. American Journal of Roentgenology|July 15, 2026
Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: <i>AJR</i> Expert Panel Narrative ReviewWonkyu P Choi, Frankis G Almaguel, Elisa Franquet-Elia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2022
Matched-pair analysis of [<sup>177</sup>Lu]Lu-PSMA I&T and [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerPhilipp E Hartrampf, Franz-Xaver Weinzierl, Andreas K Buck, et al.
Pageof 64

Showing results (511-520 of 632) with videos related to

Sort By:
Pageof 64
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 29, 2024
CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PETAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
JAMA Network Open|May 6, 2022
Mistreatment Experiences, Protective Workplace Systems, and Occupational Distress in PhysiciansSusannah G Rowe, Miriam T Stewart, Sam Van Horne, et al.
Nature Communications|February 29, 2020
Cation-controlled wetting properties of vermiculite membranes and its promise for fouling resistant oil-water separationK Huang, P Rowe, C Chi, et al.
Molecular Imaging|June 30, 2020
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [<sup>124</sup>I]FIAU PET/CTSteve Y Cho, Steven P Rowe, Sanjay K Jain, et al.
Diagnostic and Interventional Imaging|August 2, 2025
Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor typesJorge D Oldan, Anurag Anugu, Md Zobaer Islam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand TherapyPhilipp E Hartrampf, Patrick W Mihatsch, Anna Katharina Seitz, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 28, 2015
Prostate-specific membrane antigen as a target for cancer imaging and therapyA P Kiess, S R Banerjee, R C Mease, et al.
AJR. American Journal of Roentgenology|July 15, 2026
Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: <i>AJR</i> Expert Panel Narrative ReviewWonkyu P Choi, Frankis G Almaguel, Elisa Franquet-Elia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2022
Matched-pair analysis of [<sup>177</sup>Lu]Lu-PSMA I&T and [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerPhilipp E Hartrampf, Franz-Xaver Weinzierl, Andreas K Buck, et al.
Pageof 64